Literature DB >> 16289838

Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain.

Z Cai1, S Lin, L-W Fan, Y Pang, P G Rhodes.   

Abstract

The role of minocycline in preventing white matter injury, in particular the injury to developing oligodendrocytes was examined in a neonatal rat model of hypoxia-ischemia. Hypoxia-ischemia was achieved through bilateral carotid artery occlusion followed by exposure to hypoxia (8% oxygen) for 15 min in postnatal day 4 Sprague-Dawley rats. A sham operation was performed in control rats. Minocycline (45 mg/kg) or normal phosphate-buffered saline was administered intraperitoneally 12 h before and immediately after bilateral carotid artery occlusion+hypoxia and then every 24 h for 3 days. Nissl staining revealed pyknotic cells in the white matter area of the rat brain 1 and 5 days after hypoxia-ischemia. Hypoxia-ischemia insult also resulted in apoptotic oligodendrocyte cell death, loss of O4+ and O1+ oligodendrocyte immunoreactivity, and hypomyelination as indicated by decreased myelin basic protein immunostaining and by loss of mature oligodendrocytes in the rat brain. Minocycline significantly attenuated hypoxia-ischemia-induced brain injury. The protective effect of minocycline was associated with suppression of hypoxia-ischemia-induced microglial activation as indicated by the decreased number of activated microglia, which were also interleukin-1beta and inducible nitric oxide synthase expressing cells. The protective effect of minocycline was also linked with reduction in hypoxia-ischemia-induced oxidative and nitrosative stress as indicated by 4-hydroxynonenal and nitrotyrosine positive oligodendrocytes, respectively. The reduction in hypoxia-ischemia-induced oxidative stress was also evidenced by the decreases in the content of 8-isoprostane in the minocycline-treated hypoxia-ischemia rat brain as compared with that in the vehicle-treated hypoxia-ischemia rat brain. The overall results suggest that reduction in microglial activation may protect developing oligodendrocytes in the neonatal brain from hypoxia-ischemia injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289838     DOI: 10.1016/j.neuroscience.2005.09.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  47 in total

Review 1.  Microglia and the control of autoreactive T cell responses.

Authors:  Benoit Melchior; Shweta S Puntambekar; Monica J Carson
Journal:  Neurochem Int       Date:  2006-06-08       Impact factor: 3.921

2.  The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia.

Authors:  L A Pasquini; C A Calatayud; A L Bertone Uña; V Millet; J M Pasquini; E F Soto
Journal:  Neurochem Res       Date:  2006-10-25       Impact factor: 3.996

Review 3.  Neurobiology of injury to the developing brain.

Authors:  Wenbin Deng
Journal:  Nat Rev Neurol       Date:  2010-05-18       Impact factor: 42.937

Review 4.  Therapeutic potential to reduce brain injury in growth restricted newborns.

Authors:  Julie A Wixey; Kirat K Chand; Lily Pham; Paul B Colditz; S Tracey Bjorkman
Journal:  J Physiol       Date:  2018-05-23       Impact factor: 5.182

5.  Axon-glia synapses are highly vulnerable to white matter injury in the developing brain.

Authors:  Yan Shen; Xiao-Bo Liu; David E Pleasure; Wenbin Deng
Journal:  J Neurosci Res       Date:  2011-08-02       Impact factor: 4.164

6.  Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia.

Authors:  Daniel J Webber; Marka van Blitterswijk; Siddharthan Chandran
Journal:  Am J Pathol       Date:  2009-10-22       Impact factor: 4.307

7.  Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms.

Authors:  Hongxia Shen; Xiaoming Hu; Can Liu; Suping Wang; Wenting Zhang; Hui Gao; R Anne Stetler; Yanqin Gao; Jun Chen
Journal:  Neurobiol Dis       Date:  2009-12-21       Impact factor: 5.996

8.  Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease.

Authors:  John P Miller; Jennifer Holcomb; Ismael Al-Ramahi; Maria de Haro; Juliette Gafni; Ningzhe Zhang; Eugene Kim; Mario Sanhueza; Cameron Torcassi; Seung Kwak; Juan Botas; Robert E Hughes; Lisa M Ellerby
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

Review 9.  Progress in periventricular leukomalacia.

Authors:  Wenbin Deng; Jeanette Pleasure; David Pleasure
Journal:  Arch Neurol       Date:  2008-10

10.  Minocycline inhibits glial proliferation in the H-Tx rat model of congenital hydrocephalus.

Authors:  James P McAllister; Janet M Miller
Journal:  Cerebrospinal Fluid Res       Date:  2010-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.